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Abstract
Background: The intracellular bacterium Chlamydia pneumoniae is suspected to play a role in
formation and progression of atherosclerosis. Many studies investigated cell death initiation versus
inhibition by Chlamydia pneumoniae in established cell lines but nothing is known in primary human
aortic smooth muscle cells, a cell type among others known to be involved in the formation of the
atherosclerotic plaque. Type of cell death was analyzed by various methods in primary aortic
smooth muscle cells after infection with Chlamydia pneumoniae to investigate a possible pathogenic
link in atherosclerosis.
Results: Chlamydiae were found to be localized up to 72 h post infection in aortic smooth muscle
cells either as single bacteria or inside of large inclusions. Quantification of host cell death by lactate
dehydrogenase release assay revealed strictly dose and time dependent lysis for all tested isolates
of  Chlamydia pneumoniae. Phosphatidylserine exposure was detected by flow cytometry in
Chlamydia pneumoniae infected cells. Ultrastructure of Chlamydia pneumoniae infected human aortic
smooth muscle cells showed extensive membrane- and organelle damage, chromatin condensation
but no nuclear fragmentation. DNA fragmentation as well as cell membrane permeability was
analyzed by TUNEL and NHS-biotin staining and occurred exclusively in cells carrying Chlamydia
pneumoniae spots but not in smooth muscle cells with inclusions. These morphological features of
cell death were not accompanied by an activation of caspase-3 as revealed by analysis of enzyme
activity but involved mitochondrial membrane depolarization as shown by TMRE uptake and
release of cytochrome c from mitochondria.
Conclusion: This study provides evidence that Chlamydia pneumoniae induce a spot like infection
in human aortic smooth muscle cells, which results in a chimeric cell death with both apoptotic and
necrotic characteristics. This aponecrotic cell death may assist chronic inflammation in
atherosclerotic blood vessels.
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Background
Infection with Chlamydia pneumoniae (Cpn) usually causes
acute respiratory tract infections [1]. Chronical infection
with Cpn may also contribute to formation and progres-
sion of atherosclerotic lesions apart from the classical risk
factors such as hypertension, hypercholesterolemia and
hyperlipidemia [2]. Cpn has been extensively studied in
the context of atherosclerosis [3] because atherosclerosis
and cardiovascular disease are the leading causes of death
in the United States, Europe and much of Asia [4,5]. The
obligate intracellular bacterium has been detected in
atherosclerotic lesions by immunohistochemistry,
polymerase chain reaction and electron microscopy [6-8]
and has also been cultured from atheromatous plaques
[9,10]. On the cellular level smooth muscle cells and mac-
rophages in the intima have been found to be infected
with Cpn [11,12]. In general terms, if the inflammatory
response does not effectively neutralize or remove the
offending agents, such as Cpn, it can continue indefinitely
resulting in the progression of the disease [2].
Chlamydiae  exhibit a unique developmental cycle with
two morphological distinct infectious and reproductive
forms: the elementary- and the reticulate body. The life
cycle proceeds for 48 – 72 h and ends with pathogen
release that may damage the host cells [13]. Infection with
this pathogen is accompanied by cytoplasmic alterations
and damage of the host cells [12]. A balance between pro-
and anti-apoptotic influences by Chlamydia can be postu-
lated. On one hand it has been shown that Chlamydia psit-
taci and Chlamydia trachomatis can induce apoptosis in
vitro  [14,15]. On the other hand established cell lines
infected with Cpn or Chlamydia trachomatis were protected
from apoptotic cell death induced by various stimuli
[16,17]. Most of the studies investigating pro- and anti-
apoptotic activity of Cpn were performed in tumor cells or
established cell lines. Since the character of cell death is
affected by host cell type and Chlamydia strain it is of rele-
vance to determine cell death in Chlamydia infected pri-
mary cells [18]. As regards the role of Cpn in
atherosclerosis we need to understand death promoting
and inhibiting capacities of Cpn in primary cultures of
vascular cells.
Human aortic smooth muscle cells (HASMC) play an
important role in the development of atherosclerotic
lesions [19]. Therefore, we sought to clarify the nature of
cell death induced by Cpn in HASMC.
Apoptosis and necrosis represent two extreme morpho-
logically defined forms of cell death [20-23]. Recently the
hybrid term aponecrosis was introduced describing the
incomplete execution of the internal apoptotic pathway
and the following necrotic degeneration [24]. Whether
smooth muscle cell death is apoptotic, necrotic or even
aponecrotic in nature would predictably influence the
inflammatory response in the plaque. Necrotic cells
releasing their contents provoke inflammation, whereas
in apoptosis dead cells are ingested by neighboring cells
and, therefore, do not provoke an inflammatory response
[25]. In order to characterize the fate of HASMC following
infection with Cpn we analyzed cell death by morpholog-
ical and biochemical methods.
Results
Various morphological characteristics of bacterial 
infection in HASMC
In order to examine the morphological characteristics of
Cpn infection HASMC as well as the tumor cell line HEp-
2 were infected with Cpn-K6 and Cpn-VR1310, respec-
tively, and stained after 24 h, 48 h and 72 h with anti-Cpn-
MOMP antibody. According to the staining protocol
intra- and extracellular localization of Cpn could be dis-
tinguished (Figure 1). Already after 24 h, but also after 48
h and 72 h, HASMC as well as HEp-2 cells were infected
with numerous bacteria. Round or oval shaped smooth
bordered intracellular inclusions were found in tumor
cells (Figure 1E) as well as HASMC (Figure 1B,D). In con-
trast to tumor cells in primary HASMC Cpn were found
also as single or rarely as irregular shaped, aggregated
immunoreactive spots (Figure 1A, C, 4D). Quantification
of morphology in HASMC revealed that after 72 h all cells
were infected with at least one chlamydial spot (100%
infection rate). Approximately 25% of the cells carried
one or multiple inclusions. The different morphological
characteristics in HASMC (inclusions, single and aggre-
gated spots) could also be discriminated 48 h post infec-
tion. The ratio of cells carrying inclusions versus cells
carrying spots was much higher in HEp-2 cells compared
to HASMC irrespective of the infectious dose (Figure 2A).
This ratio did not considerably vary between different
Cpn strains K6 and VR1310 or as a function of the
number of bacteria used for infection. Spots were usually
much lower in number and not as prominently observed
in HEp-2 cells compared to HASMC (Figure 2C). In
HASMC the number of spots increased with higher infec-
tious doses while at the same time the number of inclu-
sions remained constant (Figure 2B) in contrast to Cpn
infections of HEp-2 cells where more inclusions were
formed at higher infectious doses without an increase of
spots.
Cpn lyse HASMC in a dose-dependent manner
To compare the lytic capacity of different Cpn isolates and
to identify a possible time course of host cell death during
the chlamydial infectious cycle, LDH release of HASMC
was analyzed at 24, 48 and 72 h post infection.
HASMC were inoculated with two different Cpn isolates:
Cpn-VR1310 and Cpn-K6 at serial 2-fold dilutionsBMC Microbiology 2005, 5:2 http://www.biomedcentral.com/1471-2180/5/2
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Diverse morphology of Cpn infection Figure 1
Diverse morphology of Cpn infection. HASMC (A, B, C and D) and HEp-2 cells (E) were infected for 72 h with Cpn-K6 at 
128 IFU/cell (HASMC; A, B), Cpn-VR1310 at 8 IFU/cell (HASMC; C, D) and Cpn-K6 at 5 IFU/cell (HEp-2; E), respectively. Bac-
teria localized on the cell surface are stained with FITC (green), Chlamydia internally localized are stained with Texas Red (red) 
and FITC (for detail see material and methods). DNA of bacteria and host cells is stained with DAPI (blue). N = nucleus. Left 
row: extracellular Cpn. Middle row: extra- and intracellular Cpn. Right row: overlay of left- and middle row and DAPI staining. 
A, C: spot like infection of a HASMC; note that the majority of bacteria are localized intracellularly B, D: HASMC with a Cpn 
inclusion. E: Hep-2 cells with Cpn inclusions.
A
extracellular Cpn extra- and intracellular Cpn overlay extra / intracellular Cpn + DNA
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ranging from 1 to 32 inclusion forming unit (IFU)/cell
(Figure 3). Both isolates were found to be free of Myco-
plasma spec. contamination as assessed by PCR. LDH
release of mock treated HASMC or of cells inoculated with
Ratio of cells with inclusions versus cells with spots Figure 2
Ratio of cells with inclusions versus cells with spots 
HASMC and HEp-2 were infected with Cpn-K6 or Cpn-
VR1310. Cells carrying inclusions or spots, respectively, 
were counted 48 h post infection. A: Depicted is the ratio of 
cells with inclusions versus cells with spots; -◆ -: HASMC 
Cpn-K6 infected, -■ -: HASMC Cpn-VR1310 infected, --: 
HEp-2 Cpn-K6 infected, --: HEp-2 Cpn VR1310 infected B: 
inclusions / cell, C: spots / cell; black bars: HASMC, open 
bars: HEp-2 cells. The number of inclusions / cell in HASMC 
remained constant in contrast to the number of spots / cell 
when increasing the infectious dose, whereas in HEp-2 cells 
the number of inclusions / cell increases and the spots / cell 
remain constant.
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Lytic capability of different Cpn isolates Figure 3
Lytic capability of different Cpn isolates. HASMC were 
infected with two different Cpn isolates. LDH release was 
measured in triplicates 24 h, 48 h and 72 h post infection and 
Cpn specific lysis was calculated. The average and standard 
deviation is plotted. One representative result out of three 
independent experiments is shown. A: Dose dependent Cpn 
specific lysis after 48 h revealed different capacities of the 
isolates tested to lyse HASMC. B: Different amounts of the 
various Cpn isolates leading to a comparable lysis over time 
of HASMC. Isolates were used as follows: Cpn-VR1310, 4 
IFU/cell -◆ -, Cpn-K6, 32 IFU/cell -■ -
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heat inactivated bacteria was comparable to the spontane-
ous LDH release of uninfected cells (data not shown).
Both Cpn isolates lysed HASMC in a strictly dose depend-
ent fashion at all time points analyzed. Cpn mediated
host cell lysis at 48 h post infection is shown in figure 3A.
Data obtained from 24 h and 72 h post infection were
similar and consistent with the displayed data subset. The
levels of HASMC lysis induced by infection with 8 IFU/cell
of Cpn-K6 (0.9% ± 3) and Cpn-VR1310 (18.6% ± 8) indi-
cate large differences in the lytic capabilities of both Cpn
isolates. Comparison of Cpn-induced LDH release at dif-
ferent time points (24, 48 and 72 h) demonstrated a con-
stant increase in Chlamydia-specific HASMC lysis
indicating continuous triggering of cell death throughout
the whole infectious cycle (Figure 3B). In order to reach
the same amount of HASMC lysis (27% ± 2) 4 IFU/cell of
Cpn-VR1310 and 32 IFU/cell of Cpn-K6 respectively were
required. This suggests that for a given degree of HASMC
lysis either high amounts of a lytically less active isolate or
lower amounts of a lytically more active isolate are
required.
Cpn infection of HASMC causes nuclear chromatin 
condensation as well as extensive damage of organelles 
and cell membrane
In order to discriminate between apoptotic and necrotic
cell death of infected HASMC ultrastructural analysis by
transmission electron microscopy (TEM) was carried out.
As a control apoptosis was induced by treatment with the
well described kinase inhibitor staurosporin.
Untreated HASMC had an elongated nucleus rich in
euchromatin with one or two well-defined nucleoli
(Figure 4A). The cytoplasm was scattered by numerous
narrow-spaced profiles of rough endoplasmic reticulum
(rER), a small Golgi complex and single elongated mito-
chondria. In Cpn infected cultures a variable number of
HASMC harbored large inclusions containing many infec-
tious elementary bodies and metabolically active reticular
bodies (Figure 4B). The nucleus of these cells was slightly
rounded but chromatin structure as well as morphology
of organelles was unchanged. A large number of infected
HASMC without Cpn inclusions were destroyed (Figure
4C). The round shaped nuclei showed a distinct conden-
sation of heterochromatin and condensed nucleoli. Cell
organelles including mitochondria and rER profiles were
dilated and cell membranes were completely disrupted.
Detection of single bacteria by TEM was possible only on
rare occasions since distorted organelles in dying cells
were barely distinguishable from Cpn.
Apoptotic HASMC treated with staurosporin showed a
distinct condensation of chromatin (Figure 4D) and
nuclei were fragmented frequently; damage of cell mem-
branes and swelling of organelles appeared to a lower
extent than in Cpn infected HASMC.
In general the overall ultrastructural morphology of
HASMC infected with spot-like Cpn infection suggests a
hybrid form of cell death: it shares chromatin condensa-
tion with apoptosis and damage of organelles and mem-
branes with necrosis.
Spot-like infection induces aponecrotic morphology in 
HASMC
The combination of chromatin staining by DAPI with
labeling of DNA strand breaks via TUNEL staining and
assessment of membrane integrity by NHS-biotin staining
allows a distinction between necrosis as well as early and
late phases of apoptosis using confocal laser scanning
microscopy [23]. Cells dying by necrosis exhibit NHS-
biotin labeling of the cytoplasm but not chromatin con-
densation or TUNEL staining of nuclei. Cells in early
phases of apoptosis display nuclei with condensed or frag-
mented chromatin, with or without TUNEL staining, and
are surrounded by NHS-biotin negative cytoplasm due to
intact cell membranes. In late phases of the apoptotic cell
death TUNEL positive nuclei occur together with a NHS-
biotin positive cytoplasm.
HASMC were infected with Cpn for chosen periods of
time or were inoculated with mock isolates or treated with
staurosporin. Cells infected with Cpn-VR1310 (Figure 5E,
F) showed an identical staining pattern as cells infected
with Cpn-K6 (Figure 5A – D).
Mock inoculated cells displayed round or oval shaped
nuclei with finely dispersed chromatin visualized by DAPI
staining and were always TUNEL negative. NHS-biotin
was bound exclusively to the cell surface indicating intact
membranes (Figure 5G).
In Cpn infected cultures a variable labeling pattern of
HASMC was observed. Cells with Cpn inclusions always
displayed normal chromatin staining and no TUNEL or
NHS-biotin labeling (Figure 5A). HASMC with spot-like
infection either contained an unaltered nucleus and NHS-
biotin negative cytoplasm (Figure 5B) or showed a TUNEL
positive nucleus with condensed chromatin embedded in
NHS-biotin stained cytoplasm (Figure 5C, E). In HASMC
displaying both Cpn spots and aggregates the nucleus was
always labeled by TUNEL and the cytoplasm by NHS-
biotin (Figure 5E, F). Cpn-infected HASMC never showed
membrane damage in combination with an unaltered
nucleus, representing necrotic cell death. Cpn-infected
HASMC displaying TUNEL positive nuclei and damaged
membranes could be detected at 24, 48 and 72 h post
infection. 8 h post infection was the earliest time point
when TUNEL positive nuclei could be detected, suggestingBMC Microbiology 2005, 5:2 http://www.biomedcentral.com/1471-2180/5/2
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Ultrastructure of Cpn infected HASMC Figure 4
Ultrastructure of Cpn infected HASMC. Cells were either infected with 128 IFU/cell Cpn-K6 for 72 h (B,C) or incubated 
with staurosporin 1 µM for 16 h (D) or were left untreated (A). A: Untreated HASMC with normal ultrastructure, note the 
elongated nucleus with finely dispersed euchromatin. B: HASMC with a typical Cpn inclusion. The membrane bound vesicle 
contains dark (= elementary bodies) and pale (= reticular bodies) stained bacteria. The chromatin structure in the nucleus is 
unchanged. C: Cpn infected HASMC undergoing cell death. The nucleus is characterized by highly condensed heterochromatin 
(arrow head) and a compact nucleolus and is surrounded by dilate organelles (arrow). The cell membrane is completely dis-
rupted. D: Staurosporin treated HASMC. The nucleus is partially fragmented containing patchy condensed heterochromatin 
(arrow heads).
2 µ µ µ µ µm
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CD
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induction of apoptosis during the whole life cycle of Cpn
(not shown). TUNEL-positive HASMC were found even at
infectious doses of 1 IFU / cell for Cpn-VR1310 and 8 IFU
/ cell for Cpn-K6 and the amount of TUNEL-positive
HASMC increased strictly dependent on the chlamydial
dose used for infection (Figure 5I). Again, both Cpn
Light microscopic analysis of the effect of Cpn infection on HASMC Figure 5
Light microscopic analysis of the effect of Cpn infection on HASMC. HASMC were infected with Cpn-K6 128 IFU/
cell (A, B, C, D), Cpn-VR1310 32 IFU/cell (E, F) for 72 h or were inoculated with mock lysate (G) or treated with staurosporin 
1 µM for 14 h (H). The cells were subsequently stained for TUNEL (green), NHS-biotin (brown), anti-Cpn-MOMP (red) and 
DNA (blue). A: HASMC bearing a Cpn-K6 inclusion. DAPI stained chromatin structure is normal and TUNEL as well as NHS-
biotin labeling are negative. B: Cpn-K6 infected HASMC with multiple chlamydial spots (arrow heads) and normal nuclear 
structure. C, E: Cpn-K6 (C) or Cpn-VR1310 (E) infected HASMC with spot like infection (arrow heads). The condensed 
nucleus is TUNEL positive, the cytoplasm is diffusely labeled with NHS-biotin. D, F: HASMC with Cpn-K6 (D) or Cpn-VR1310 
(F) in aggregated (arrow) spots and single spots (arrow heads). Note positive TUNEL labeling of the shrunken nucleus and 
NHS-biotin staining of the cytoplasm. G: Mock inoculated HASMC. Note the fine granular chromatin structure and lack of 
TUNEL- and cytoplasmic NHS-biotin staining. H: HASMC incubated with staurosporin. The nucleus exhibits a distinct nuclear 
fragmentation (DAPI staining) but no TUNEL labeling. The cytoplasm is NHS-biotin negative indicating an intact cell membrane. 
I: Quantification of TUNEL positive nuclei depending on the chlamydial infectious dose 72 h post infection reveals a dose 
dependent increase of TUNEL positive cells. Cells in 5 random fields with an area of 62'500 µm2 were counted and the per-
centage of TUNEL positive cells was calculated. -▲ -: Cpn-K6; -■ -: Cpn-VR1310
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strains used in this study elicited the same features of cell
death in HASMC according to the infection morphology.
Identical to the lytic capacity (Figure 3A) of these strains,
K6 had to be used at higher IFU compared to VR1310 to
generate a similar number of cells with TUNEL-positive
nuclei and NHS-biotin positive cytoplasm. In contrast to
HASMC neither Cpn-K6 nor Cpn-VR1310 induced a con-
centration dependent increase in TUNEL positive nuclei
in HEp-2 cells and numbers of TUNEL positive nuclei
remained below 10% (not shown).
In staurosporin treated cells the rounded nuclei were frag-
mented or exhibited chromatin that was condensed mar-
ginally, whereas NHS-biotin labeling was predominantly
negative (Figure 5H). Just a minority of the cells revealed
a condensed TUNEL-positive nucleus and at the same
time were also NHS-biotin positive reflecting late stages of
apoptotic cell death.
Cpn infection induces phosphatidylserine externalization 
in HASMC
HASMC were infected for 48 h with Cpn-K6 or -VR1310
in 2-fold dilutions ranging from 8 to 386 IFU/cell or from
1 to 32 IFU/cell, respectively. As controls cultures were
inoculated with mock isolates or with heat inactivated
bacteria (data not shown) and analyzed for annexin-V
binding and propidium iodide uptake. Uninfected as well
as Na-azide treated HASMC served as negative and stau-
rosporin-treated cells as positive controls for apoptosis
(Figure 6C upper right and upper left panel). Control cul-
tures inoculated with mock lysate (Figure 6) or heat inac-
tivated bacteria and untreated cells showed always less
than 20% annexin-V single positive cells. This proportion
of annexin-V positive cells represented background stain-
ing, probably due to the experimental procedure. Upon
infection with 128 IFU/cell of Cpn-K6 for 72 h the
number of single annexin-V positive cells increased to
more than 50% (Figure 6B). Upon Cpn infection annexin-
V and propidium iodide double-positive staining reached
10% as compared with 4% in mock-inoculated and 3% in
untreated HASMC (not shown). In staurosporin treated
cultures the amount of both annexin-V single and double
positive cells increased strongly (Figure 6 upper left panel)
indicating a continued induction of classical apoptotic
cell death.
The amount of annexin-V single positive HASMC infected
with Cpn increased linearly in a dose- (Figure 6A) and
time- (Figure 6B) dependent manner. Cpn-VR1310 again
induced phosphatidylserine externalization at much
lower doses compared to Cpn-K6. Neither mock inocula-
tion (Figure 5A, B6C lower left panel), nor inoculation
with heat inactivated bacteria (data not shown), induced
apoptosis. This indicates that infection with living bacte-
ria is required for induction of cell-death.
Taken together, the dose- and time dependence between
infection and phosphatidylserine externalization were
consistent with induction of early apoptotic events.
Chlamydia infection in HASMC induces caspase-3 
independent cell death by dissipation of mitochondrial 
membrane potential
After induction of apoptosis an enzymatic cascade is acti-
vated leading to the disassembly of the cell [23]. Key
enzyme in this cascade is caspase-3. However, in some
cases apoptosis can proceed without involvement of cas-
pase-3 [26]. In order to investigate the role of caspase-3
HASMC were infected with Cpn-K6 128 IFU/cell or Cpn-
VR1310 32 IFU/cell, respectively, for 48 h (24 h and 72 h
not shown) or treated with 1 µM staurosporin for 12 h to
induce apoptosis. Samples were analyzed for caspase-3
activation by measuring enzyme activity after lysing the
cells. No activity of caspase-3 in Cpn infected HASMC
(Figure 7A) could be detected. In contrast distinct caspase-
3 activity was found in staurosporin-treated cells.
A major role in the induction and regulation of cell death
is played by mitochondria. Pro-apoptotic factors result at
mitochondria in the dissipation of the mitochondrial
membrane potential and release of cytochrome c. After
infection of HASMC with Cpn-K6 or Cpn-VR1310 cells
were loaded with TMRE
(tetramethylrhodamineethylester) [27], a dye, that is only
taken up into mitochondria with an intact mitochondrial
potential [28]. Cells with intact membranes excluding
propidium iodide were analyzed by flow cytometry.
The number of TMRE negative cells strictly increased with
the chlamydial dose whereas blocking of chlamydial pro-
tein synthesis by addition of chloramphenicol completely
abrogated this effect (Figure 7B). Moreover, labeling of
Cpn-K6 infected or mock treated cells for cytochrome c
and mitotracker red revealed distinct loss of cytochrome c
staining of the mitochondria in the infected population
(Figure 7D) but not in mock treated cells (Figure 7C).
Taken together, the data suggest Chlamydia pneumoniae
induce caspase-independent apoptosis-like cell death in
infected HASMC by involving mitochondrial membrane
dissipation resulting in the release of cytochrome c.
Discussion
In our in vitro study cell death was only induced in
HASMC by infection with viable Cpn but not after incuba-
tion with heat inactivated or chloramphenicol treated
bacteria. Additionally, different Cpn isolates showed
various lytic activities towards host cells that correlated to
different reproduction rates in tumor cells as measured by
real time PCR [29]. A reproductive infection would seem
to be a prerequisite for cell death induction in HASMC.BMC Microbiology 2005, 5:2 http://www.biomedcentral.com/1471-2180/5/2
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Dose response relationship between bacterial titer and phosphatidylserine exposure in Cpn infected HASMC Figure 6
Dose response relationship between bacterial titer and phosphatidylserine exposure in Cpn infected HASMC. 
Cells infected with Cpn-K6 in doses between 8 – 386 IFU/cell or with Cpn-VR1310 in doses between 1 – 32 IFU/cell were 
stained with annexin-V / propidium iodide and analyzed by flow cytometry 48 h post infection. Mock inoculated cells are shown 
as controls. In figure A and B pooled data out of three independent experiments are displayed. A: The amount of single 
annexin-V positive cells increased dependent on the chlamydial infectious dose (-◆  -: Cpn-K6; -● -: Cpn-VR1310) but not in 
mock treated (-❍ -) cells. (*: significant compared to mock treated cells with p < 0.001) B: the number of single annexin-V pos-
itive cells increased over the time when cells were infected with Cpn-K6 128 IFU/cell (-● -) but not if they were mock treated 
(-❍ -) (significant compared to mock treated cells with p < 0.001)(#)). C: Dot plots of one representative experiment are 
depicted to illustrate the amount of annexin V / propidium iodide double labeled cells. Upper left panel: HASMC treated with 
staurosporin (apoptosis). Upper right panel: HASMC treated with Na-azide (necrosis). Middle left panel: HASMC infected with 
Cpn-VR1310 at 32 IFU / cell 48 h post infection. Middle right panel: HASMC infected with Cpn-K6 at 128 IFU / cell 48 h post 
infection. Lower left panel: mock treated HASMC.
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Caspase 3 activity and mitochondrial membrane permeability Figure 7
Caspase 3 activity and mitochondrial membrane permeability A: Caspase-3 activity was assessed in HASMC infected 
with 128 IFU/cell Cpn-K6 ± Chloramphenicol (CA), loaded with mock isolate or treated with 1 µM staurosporin for 14 h. No 
caspase-3 activity can be detected in Cpn infected or mock inoculated cells in contrast to staurosporin treated cells. B: 
HASMC were infected with 4 – 128 Cpn-K6 (-● -) or 4 – 32 IFU/cell Cpn-VR1310 (-◆ -) and stained by TMRE for detection of 
mitochondrial membrane potential in combination with propidium iodide. Propidium iodide negative cells were analyzed by 
flow cytometry for TMRE staining. Infected HASMC treated with 0.1 µg/ml chloramphenicol served as controls (open sym-
bols). Loss of TMRE staining is induced in HASMC infected with viable Cpn but not in cells infected with Cpn treated with chlo-
ramphenicol. Mean values with standard error of three independent experiments are shown. C, D: HASMC were infected with 
Cpn-K6 (IFU 128 IFU/cell, 48 h) and stained for cytochrome c (white). Mitochondria were labeled with mitotracker red (red). 
Loss of cytochrome c staining is found in mitochondria of HASMC infected with Cpn (D) but not in mock treated cells (C).
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The observation that heat inactivated or chloramphenicol
treated bacteria never caused changes of the host cells
underlines that cell death induction is not a bystander
effect of a potential cytopathic chlamydial component
such as the heat stable LPS. It can be concluded that
HASMC death depends on internalization of the Chlamy-
dia and is associated with the suppression of bacterial rep-
lication and productive infection. The necessity for a
reproductive infection was also shown for Chlamydia psit-
taci which induced caspase 3 independent apoptosis in
macrophages and epithelial cells only after reproductive
infection along with bacterial protein synthesis [15]. Cell
death induction was never found in cells harbouring
inclusions which normally are viewed as the manifesta-
tion of a reproductive infection. HASMC formed inclu-
sions with a relatively low frequency compared to tumor
cells. In contrast, spots resulting presumably from single
bacteria were found frequently illustrating a different
infection morphology of Cpn in these primary vascular
cells. Currently no data are available regarding metabo-
lism, protein synthesis and reproduction or functional
relation with host cells of these single, spot-like bacteria.
From our data it only can be concluded that these single
bacteria are sensitive to chloramphenicol which inhibits
protein synthesis in Cpn and abrogates cell death induc-
tion. Cell death seems to result from an interaction of the
host cell with these single bacteria as it is ongoing for
extended times.
Cpn induced cell death in HASMC did not fulfill all crite-
ria for apoptosis or classical necrosis. Condensation of
chromatin, positive TUNEL staining, externalization of
phosphatidylserine, inhibition of TMRE labeling and loss
of cytochrome c immunoreactivity in mitochondria were
clear markers for apoptosis. But early damage of cell mem-
brane and organelles as found by TEM and NHS-biotin
labeling indicated necrotic type of cell death in Cpn
infected cells. According to previous classifications Cpn
mediated cell death belongs to apoptosis-like cell death
[30] or can be termed aponecrosis due to characteristic
ultrastructural features [24]. Cpn induced cell death in
HASMC having features of necrosis and apoptosis is in
agreement with a study employing mouse embryonic
fibroblasts infected with C. trachomatis which died
through a combination of necrosis and apoptosis [18].
If cell death induction by Cpn in HASMC is caspase-3
independent the question arises about alternative path-
ways that are involved. Mitochondria are important regu-
lators of cell death and loss of mitochondrial permeability
transition is an important indication for apoptosis [31].
Here we show by TMRE labeling dissipation of the mito-
chondrial potential of Chlamydia infected cells. This effect
could be inhibited by blocking bacterial protein synthesis
using chloramphenicol. Moreover, cytochrome c was
released from mitochondria of infected HASMC as indi-
cated by loss of immunorecactivity. The important role of
mitochondria in Chlamydia induced cell death has also
been shown in tumor cell lines infected with Chlamydia
psittaci [14]. Pro-apoptotic Bcl-2 family members like Bax
were activated and apoptosis induction occurred during
the whole chlamydial life cycle. Apoptosis induced by
Chlamydia psittaci was blocked in cells over expressing Bax
inhibitor and anti-apoptotic Bcl-2 [14]. Bax-/-  mouse
embryonic fibroblasts were shown to be resistant to
Chlamydia muridarum-induced apoptosis and fewer bacte-
ria were recovered after two infection cycles. This suggests
that Bax-dependent apoptosis may be used to initiate a
new round of infection [32]. In a second study, Chlamydia
trachomatis infected mouse fibroblasts showed a higher
level of apoptosis than Chlamydia infected HeLa cells as
measured by annexin V / propidium iodide double labe-
ling [18]. This not only shows that Bax activation could
reflect a stress response in infected cells [33] but that pri-
mary cells show a different stress response to Chlamydia
infection than tumor cells.
Beside Bax other factors like apoptosis-inducing factor
(AIF) may be involved in caspase-independent cell death
[34] but they have never been investigated in Chlamydia-
induced cell death. AIF which is upregulated and translo-
cated from the mitochondria to the cytosol may play an
important role in induction of caspase-3 independent cell
death [34-36]. Injection of AIF into the cytoplasm induces
similar chromatin condensation coupled to phosphati-
dylserine exposure as we found in Cpn infected HASMC
[37]. Future experiments will have to show if AIF, Bax or
other Bcl-2 family members are involved in Cpn induced
HASMC death.
There exist numerous studies showing that Cpn and
Chlamydia trachomatis prevent cells in vitro from undergo-
ing apoptosis [16,17,38-44]. However, these experiments
were performed on established cell lines. Our study shows
that in primary cultures of cells such as HASMC various
types of Cpn infection occur. Spot like infection resulted
in aponecrosis whereas cells with Cpn inclusions
appeared to be prevented from cell death. Apparently Cpn
in inclusions have evolved strategies to inhibit cell death
presumably to complete the developmental cycle. About
possible mechanisms can be speculated: it has been
shown that Cpn inserts components of a type-III secretion
system into the inclusion membrane [45] and releases fac-
tors into the host cell [46-48] that affect host cell metabo-
lism. Cpn secretes proteins that translocate from the
inclusion to the cytoplasm [47,49]. CADD, a secreted
protein from Chlamydia trachomatis, has been shown to
interact with death domains and co-localizes with Fas.
Recombinant CADD has been shown to induce caspase
dependent apoptosis in several tumor cell lines [50].BMC Microbiology 2005, 5:2 http://www.biomedcentral.com/1471-2180/5/2
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Therefore, other yet unidentified proteins from Chlamydia
could interact with the host cell death machinery and
inhibit or promote cell death.
Currently, it is unclear how the observed morphology of
Cpn in HASMC and the induced aponecrotic cell death
affects the progression of atherosclerosis. Cpn infection of
HASMC was accompanied by phosphatidylserine exter-
nalization which might result in the ingestion of dying
cells by macrophages. Macrophages will then either stop
further progress of Cpn mediated damage or in turn
become activated and thereby contribute to inflammation
in the atherosclerotic vessel [51,52]. Early membrane
damage found in the aponecrotic HASMC may provoke or
assist inflammation in the atherosclerotic vessel due to
release of cellular constituents. Finally damage of vascular
smooth muscle cells by Cpn infection might lead to
plaque instability [19].
Conclusions
Cpn infection of cultured HASMC results in cell death that
can be termed aponecrosis due to the sharing of apoptotic
and necrotic features. This form of cell death occurs just in
cells bearing single or aggregated bacteria but not in cells
with inclusions. Aponecrotic HASMC may in vivo assist
chronic infection in the vascular wall supporting the pro-
gression of atherosclerosis.
Methods
Chlamydial organisms, cells, antibodies and reagents
Cpn-VR1310 and Cpn isolate Kajaani 6 (Cpn-K6) were
kindly provided by G. Christiansen (Institute of Microbi-
ology and Immunology, University Aarhus, Denmark)
and M. Puolakkainen (Haartman Institute, University of
Helsinki, Finland), respectively.
HEp-2 cells obtained from ATCC (Manassas, USA) were
cultivated in MEM-Eagle's (Gibco BRL, Invitrogen, Basel,
Switzerland) and HASMC purchased from Clonetics
(Verviers, Belgium) were maintained in DMEM supple-
mented with 10% FCS, 2 mM glutamine, all from Gibco
BRL, Invitrogen, and 10 µg/ml neomycin (Sigma Chemi-
cals, Buchs Switzerland). Cells and chlamydial organisms
were tested for Mycoplasma spec. contamination by PCR
[53] and 4',6-Diamidin-2'-phenylindol-dihydrochloride
(DAPI) (Roche, Mannheim, Germany) staining and were
mycoplasma free.
Anti-Cpn-MOMP monoclonal antibody was from DAKO
(Zug, Switzerland); anti-cytochrome c antibody raised in
sheep was from Sigma, FITC-labeled monoclonal anti-
Chlamydia-LPS antibody from Biorad (Redmont, USA).
Donkey anti-mouse polyclonal antibody was obtained
from Jackson Immuno Research (Baltimore, USA) and
staurosporin from Sigma Chemicals.
Chlamydial culture and infection of HASMC
Cpn was cultured according to an established protocol
[54]. Briefly, confluent HEp-2 cells were inoculated with
Cpn at 1 IFU/cell in medium, centrifuged at 1000 × g for
1 h and grown for 72 h in medium containing 10% FCS,
2 mM glutamine, 10 µg/ml neomycin and 2 µg/ml
cycloheximide (Sigma). Subsequently, cells were har-
vested, disrupted by sonification and bacteria were puri-
fied on a discontinuous renografin (Sigma Chemicals)
gradient as previously described [55]. Non infected HEp-
2 cells were subjected to the same harvesting / purification
procedure and referred to as mock controls. In order to
determine the chlamydial titer (IFU/ml), confluent HEp-
2 cells grown on cover slips were infected with serial 2-
fold dilutions of purified bacteria. After 72 h cells were
fixed, stained with anti-Chlamydia-LPS antibody, inclu-
sions were counted under a fluorescence microscope and
the titer was calculated.
HASMC were seeded into 6-well plates (Nunc, Roskilde,
Denmark) at a density of 2.4 × 104 cells/cm2 one day prior
to infection. Infection with chlamydial organisms was
performed in DMEM using titers between 8 and 386 IFU/
cell which were added to HASMC, centrifuged onto the
cells for 1 h at 1000 × g. Subsequently, the supernatant
was replaced by DMEM containing 10% FCS, 2 mM
glutamine and 10 µg/ml neomycin. In some experiments
chloramphenicol 0.1 mg/ml was added analysis or cells
were treated with 1 µM staurosporin for 14 h. Cells were
grown at 37°C in the presence of 5% CO2 until they were
analyzed.
Determination of infection morphology, intra- versus 
extracellular staining of Cpn
Live HASMC and HEp-2 cells were incubated with anti-
Cpn-MOMP antibody (1:50) in PBS + 2% BSA for 1 h at
room temperature (RT). After washing and fixation with
2% paraformaldehyde + 3% sucrose in PBS at RT, cells
were incubated for 1 h with donkey anti-mouse-FITC anti-
body, diluted 1:100 in PBS + 2% BSA. Bacteria located
extracellularly are stained exclusively green by this step.
Subsequently, cells were lysed with 0.1% Triton-X 100 for
1 min at RT, rinsed with PBS + 2% BSA for 20 min, and
incubated with anti-Cpn-MOMP antibody (1:50) fol-
lowed by Texas Red-labeled donkey anti-mouse antibody
(1:200) in 2% BSA in PBS. The second staining step iden-
tifies both intracellular and extracellular bacteria.
Counting of cells with inclusions or spots as well as the
number of inclusions and spots were performed on
volume data obtained using a laser scanning microscope
(SP2, Leica, Heidelberg, Germany) followed by image
analysis using the software package Imaris (Bitplane,
Zurich, Switzerland).BMC Microbiology 2005, 5:2 http://www.biomedcentral.com/1471-2180/5/2
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Determination of cytotoxicity by lactate dehydrogenase 
release (LDH)
LDH release of HASMC was assessed using a cytotoxicity
detection kit (Roche) following the manufacturer's
instruction. In brief, HASMC were seeded in a 96-well
plate (NUNC) at a density of 2.4 × 104 cells/cm2, infected
with Cpn between 2 and 32 IFU/cell and cultivated for 24
h, 48 h and 72 h. For cell death analysis 100 µl of cell-free
supernatant was harvested, mixed with dye solution, incu-
bated for 20 min and absorption was measured at 490
nm. Percent Chlamydia-specific lysis was calculated
according to the formula: ((experimental value – sponta-
neous release)/(maximum release – spontaneous release)
× 100. Spontaneous release corresponded to untreated
HASMC and infected cells lysed additionally with Triton-
X 100 showed the maximal release.
Transmission electron microscopy (TEM)
Cells were fixed in 50 mM sodium cacodylate buffer pH
7.3 containing 2% glutaraldehyde and 0.8% paraformal-
dehyde and postfixed with 1% OsO4 in 50 mM sodium
cacodylate buffer, pH 7.3 dehydrated in an ethanol series
and embedded into epon (Catalys). Ultrathin sections of
50 nm were contrasted with uranyl acetate and lead citrate
and studied with a CM 100 transmission electron micro-
scope (Phillips, Leiden, Netherlands).
TUNEL-, NHS-biotin-, Cpn- and DAPI-staining for analysis 
by confocal microscopy
Cells were trypsinized, washed in PBS and incubated with
0.1 mg/ml NHS-biotin (Pierce, Rockford, USA) in PBS for
30 min on ice, fixed with 3% paraformaldehyde + 2%
sucrose in PBS and cytospinned onto glass slides. Samples
were permeabilized with 0.1% Triton-X 100 in PBS for 1
min at RT and stained for DNA strand breaks using termi-
nal transferase (Roche), incorporating dUTP-FITC
(Roche) overnight at 37°C as previously described [56].
Subsequently, cells were incubated with anti-Cpn-MOMP
antibody (1:50) and detected with donkey anti-mouse
Texas Red antibody (1:200) in 2% BSA in PBS for 1 h, fol-
lowed for 45 min by 0.5 µg/ml streptavidin-Cy5 (Jackson
Immuno Research) detection of NHS-biotin. Nuclei and
DNA of bacteria were stained with 1 µg/ml DAPI in PBS
for 10 min. Samples were then embedded in fluorescence
mounting medium (Dako) and analyzed using a confocal
laser scanning microscope (SP2, Leica, Heidelberg,
Germany).
Annexin-V/propidium iodide staining for flow cytometry
Phosphatidylserine exposure and propidium iodide
incorporation was assessed using the annexin-V-FLUOS
staining kit (Roche). In brief, supernatants of HASMC cul-
tures were collected and mixed with trypsinized cells.
Samples were washed in PBS followed by 20 min staining
with annexin-V / propidium iodide staining solution and
analyzed by flow cytometry (Becton Dickinson, Basel,
Switzerland).
Determination of caspase-3 activity
0.2 × 106 HASMC consisting of floating and adherent cells
were lysed at 4°C in cell lysis buffer (20 mM PIPES, pH
7.2, 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 0.1%
CHAPS, 10% sucrose), subjected to three freeze-thaw
cycles and centrifuged at 14000 × g for 10 min. Protein
content of supernatants was measured using the micro
BCA protein assay reagent kit (Pierce). Cell lysates con-
taining 40 µg protein were incubated with DEVD-p-
nitroanilide (0.8 mM) in lysis buffer and absorption was
measured every 5 min in a spectrophotometer at 405 nm
for 6 h at 37°C. Caspase-3 activity was calculated as the
initial ascending slope of absorption depicted as arbitrary
units.
TMRE and propidium iodide staining for analysis of 
mitochondrial membrane potential
Cells were stained with TMRE 100 nM and propidium
iodide 2 µg/ml in DMEM with 10% FCS for 30 min at
37°C and 5% CO2, collected by trypsinization, combined
with detached cells at time of trypsinization and analysed
by flow cytometry (Becton Dickinson).
Cytochrome c and mitotracker red staining for confocal 
microscopy analysis
Cells were incubated in the presence of 50 nM mitotracker
red for 30 min, subsequently fixed with 3% paraformalde-
hyde + 2% sucrose and were cytospinned onto glass slides.
Samples were permeabilized with 0.1% Triton-X 100 in
PBS for 1 min at RT. Subsequently stained with sheep anti
cytochrome c (1 : 2000) in 3 % BSA in PBS for 1 h at 37°C
followed by detetion with donkey anti sheep biotin anti-
body (1:200) in 0.5 % BSA in PBS for 1 h at RT. Cells were
labeled with streptavidin Cy-5 (1 : 200) for 1 h at RT and
analysed under a confocal laser scanning microscope.
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